This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Adverse event reporting can be found at the bottom of the page

Menu

Close

Click here for APEXXNAR® (GB) (pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)) GB Prescribing information. Click here for Prevenar 13® (pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.

Pneumococcal DiseasePneumococcal Disease

Pneumococcal disease refers to a group of infections caused by the bacterium, Streptococcus pneumoniae, also known as pneumococcus.
​​​​​​​

There are over 90 different strains of Streptococcus pneumoniae bacteria (known as serotypes), some of which cause more serious infection than others. It's thought that between 8 and 10 strains are responsible for two-thirds of serious infections in adults, and most cases in children.2

Classification of disease & symptomsClassification of disease & symptoms

Pneumococcal infections usually fall into one of two categories:1,2

Non-invasive pneumococcal infections: 
Occur when there is no evidence that the bacteria has spread to normally sterile body fluids and examples include otitis media (ear infection), sinusitis and pneumonia.1

Invasive pneumococcal infections: 
Occur when bacteria are detected in normally sterile body fluids such as the blood or
cerebrospinal fluid.1,2

Invasive pneumococcal infections include1,2:

  • Bacteraemic pneumonia1
    • This is the most common invasive pneumococcal infection in adults.3 It occurs when bacteria invade both the lungs and the bloodstream2
  • Bacteraemia/septicaemia3
    • This occurs when pneumococcal bacteria invade the bloodstream2
  • Meningitis1​​​​​​​
    • This occurs when pneumococcal bacteria invade the tissues and fluids surrounding the brain and spine2

Pneumococcal pneumonia is the most common clinical presentation of pneumococcal disease among adults.4 Pneumonia is swelling (inflammation) of the tissue in one or both lungs.2

Symptoms of pneumococcal pneumonia:
One of the most common symptoms of pneumonia is a cough. This can be dry or mucus producing (yellow, green, brownish or blood-stained).5

Other common symptoms are:5

  • difficulty breathing
  • rapid heartbeat
  • fever
  • feeling generally unwell
  • sweating and shivering
  • loss of appetite
  • chest pain 

While anyone can get pneumococcal disease, individuals in certain age groups or those living with certain medical conditions are at increased risk.1 

People with a weakened immune system are most at risk of catching a pneumococcal infection. This may be because:2

  • They have a serious health condition that weakens their immune system, such as HIV or diabetes
  • They are having treatment or taking medication that weakens their immune system, such as chemotherapy

Other groups at-risk of pneumococcal disease include:2

  • Babies and young children under two years of age
  • Adults over 65 years of age
  • People who smoke or misuse alcohol
Learn more about APEXXNAR®(GB)

20-valent pnuemococcal conjugate vaccine for adults that helps protect against pneumococcal disease originating from vaccine-type serotypes.6,8

Explore APEXXNAR®(GB)Loading

Learn more about Prevenar 13

Information about the indications & use of Prevenar 13 in the United Kingdom.

The use of Prevenar 13 should be determined on the basis of official recommendations taking into consideration the risk of invasive disease and pneumonia in different age groups, underlying comorbidities as well as the variability of serotype epidemiology in different geographical areas.6

Explore Prevenar 13®Loading

Burden of DiseaseBurden of Disease

Pneumococcal infections and invasive pneumococcal diseases are major causes of disease morbidity and mortality in Europe and globally, with the highest burden of disease found in young children and the elderly.7 In 2005/6, 6,346 cases of invasive pneumococcal disease were confirmed in England and Wales.1 

Cases of invasive pneumococcal infection usually peak in the winter, during December and January.2 A large proportion of invasive pneumococcal disease is vaccine preventable.7

The pneumococcus is also the most common cause of community-acquired pneumonia, as well as non-invasive, upper respiratory tract infections such as otitis media and sinusitis.7
​​​​​​​

Events

Browse and register for speaker programs

Materials

View materials for you and your patients

Videos

Find videos and on-demand webinars

References:
  1. Public Health England. The Green Book [published 2013; updated 2020]. Chapter 25: Pneumococcal. Available at https://www.gov.uk/government/publications/pneumococcal-the-green-book-chapter-25 Last accessed: April 2023
  2. NHSinform. Pneumococcal Infections. Available at: https://www.nhsinform.scot/illnesses-and-conditions/infections-and-poisoning/pneumococcal-infections Last accessed: April 2023
  3. British Lung Foundation. Pneumonia. Available at: https://www.blf.org.uk/support-for-you/pneumonia/what-is-pneumonia Last accessed: April 2023
  4. CDC. Pneumococcal Disease. https://www.cdc.gov/pneumococcal/clinicians/clinical-features.html Last accessed: April 2023
  5. NHS. Overview: Pneumonia. Available at https://www.nhs.uk/conditions/Pneumonia/ Last accessed April 2023
  6. Prevenar 13 Summary of Product Characteristics for Great Britain available at: https://www.medicines.org.uk/emc/medicine/22689/SPC/ Last Accessed: April 2023
  7. ECDC. Factsheet about pneumococcal disease Available at https://www.ecdc.europa.eu/en/pneumococcal-disease/facts Last accessed April 2023
  8. APEXXNAR GB (Pneumococcal polysaccharide conjugate vaccine). Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/13461 Last accessed April 2023
PP-UNP-GBR-8570. March 2024

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2024 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7866. January 2024
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​